INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 130 filers reported holding INOVIO PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.51 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $44,367 | -62.0% | 54,106 | -27.8% | 0.02% | -60.7% |
Q4 2022 | $116,849 | -6.5% | 74,903 | +3.3% | 0.06% | +22.0% |
Q3 2022 | $125,000 | 0.0% | 72,540 | +0.7% | 0.05% | +8.7% |
Q2 2022 | $125,000 | +33.0% | 72,014 | +174.4% | 0.05% | +9.5% |
Q1 2022 | $94,000 | -32.4% | 26,244 | -5.6% | 0.04% | -19.2% |
Q4 2021 | $139,000 | -18.7% | 27,793 | +16.5% | 0.05% | -30.7% |
Q3 2021 | $171,000 | -26.6% | 23,857 | -5.0% | 0.08% | -21.9% |
Q2 2021 | $233,000 | -13.1% | 25,105 | -13.0% | 0.10% | -15.0% |
Q1 2021 | $268,000 | +6.8% | 28,845 | +1.8% | 0.11% | +8.7% |
Q4 2020 | $251,000 | +27.4% | 28,339 | -46.5% | 0.10% | -75.2% |
Q1 2019 | $197,000 | -18.6% | 52,943 | -12.3% | 0.42% | +922.0% |
Q4 2018 | $242,000 | -58.1% | 60,398 | -41.9% | 0.04% | -31.7% |
Q3 2018 | $578,000 | -17.3% | 104,004 | -41.7% | 0.06% | -90.3% |
Q2 2018 | $699,000 | -15.1% | 178,365 | +2.0% | 0.62% | -13.4% |
Q1 2018 | $823,000 | +146.4% | 174,782 | +116.2% | 0.71% | +70.4% |
Q4 2017 | $334,000 | +28.0% | 80,850 | +96.1% | 0.42% | +1097.1% |
Q3 2017 | $261,000 | -11.2% | 41,233 | +10.1% | 0.04% | -20.5% |
Q2 2017 | $294,000 | +10.1% | 37,461 | -7.1% | 0.04% | -8.3% |
Q1 2017 | $267,000 | +5.5% | 40,328 | +10.6% | 0.05% | -36.8% |
Q4 2016 | $253,000 | +12.9% | 36,462 | +51.6% | 0.08% | -29.6% |
Q3 2016 | $224,000 | +0.9% | 24,058 | 0.0% | 0.11% | -34.5% |
Q2 2016 | $222,000 | -37.1% | 24,058 | -40.6% | 0.16% | -66.0% |
Q1 2016 | $353,000 | – | 40,487 | – | 0.49% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|